Cargando…
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.
Approximately 30-50% of cases of ovarian adenocarcinoma harbour mutations in the p53 tumour-suppressor gene associated with elevated levels of the protein detected by immunohistochemical staining. To investigate any relation between the presence of mutant p53 and clinicopathological features of dise...
Autores principales: | Renninson, J., Baker, B. W., McGown, A. T., Murphy, D., Norton, J. D., Fox, B. W., Crowther, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968836/ https://www.ncbi.nlm.nih.gov/pubmed/8123498 |
Ejemplares similares
-
Metallothionein levels in ovarian tumours before and after chemotherapy.
por: Murphy, D., et al.
Publicado: (1991) -
Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.
por: Murphy, D., et al.
Publicado: (1992) -
Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.
por: Wrigley, E. C., et al.
Publicado: (1996) -
Interaction of the novel agent amphethinile with tubulin.
por: McGown, A. T., et al.
Publicado: (1989) -
Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
por: McGown, A., et al.
Publicado: (1987)